Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Exploring the role of the epigenome in multiple sclerosis: A window onto cell-specific transcriptional potential.
Kaliszewska A, De Jager PL.
J Neuroimmunol. 2012 Jan 30. [Epub ahead of print]
Related citations
Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis.
Villoslada P, Baranzini S.
J Neuroimmunol. 2012 Jan 24. [Epub ahead of print]
Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
Foster M, Zivadinov R, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Carl E, Ramanathan M.
J Neuroimmunol. 2012 Feb 29;243(1-2):61-8. Epub 2012 Jan 18.
The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
Stojković L, Djurić T, Stanković A, Dinčić E, Stančić O, Veljković N, Alavantić D, Zivković M.
J Neuroimmunol. 2012 Apr;245(1-2):87-92. Epub 2012 Jan 18.
The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.
Pinto-Medel MJ, García-León JA, Oliver-Martos B, López-Gómez C, Luque G, Arnáiz-Urrutia C, Orpez T, Marín-Bañasco C, Fernández O, Leyva L.
J Neuroimmunol. 2012 Feb 29;243(1-2):1-11. Epub 2012 Jan 20.
Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis.
Mandel I, Paperna T, Miller A.
J Neuroimmunol. 2012 Mar;244(1-2):51-6. Epub 2012 Jan 16.
Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.
Boronat A, Sepúlveda M, Llufriu S, Sabater L, Blanco Y, Gabilondo I, Solà N, Villoslada P, Dalmau J, Graus F, Saiz A.
J Neuroimmunol. 2012 Mar;244(1-2):103-6. Epub 2012 Jan 14.
Investigating channel blockers for the treatment of multiple sclerosis: considerations with mefloquine and carbenoxolone.
Nevin RL.
J Neuroimmunol. 2012 Feb 29;243(1-2):106-7. Epub 2012 Jan 10. No abstract available.
Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis.
Chen YC, Chen SD, Miao L, Liu ZG, Li W, Zhao ZX, Sun XJ, Jiang GX, Cheng Q.
J Neuroimmunol. 2012 Feb 29;243(1-2):56-60. Epub 2012 Jan 9.
Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab.
Mulero P, Caminero AB, Neri Crespo MJ, Fernández-Herranz R, Téllez Lara N.
J Neuroimmunol. 2012 Feb 29;243(1-2):103-5. Epub 2012 Jan 5.
Diurnal rhythms are altered in a mouse model of multiple sclerosis.
Buenafe AC.
J Neuroimmunol. 2012 Feb 29;243(1-2):12-7. Epub 2011 Dec 30.
Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.
Beyer NH, Lueking A, Kowald A, Frederiksen JL, Heegaard NH.
J Neuroimmunol. 2012 Jan 18;242(1-2):26-32. Epub 2011 Dec 15.
Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X.
J Neuroimmunol. 2011 Dec 15;240-241:104-8. Epub 2011 Oct 28.
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Laugel B, Borlat F, Galibert L, Vicari A, Weissert R, Chvatchko Y, Bruniquel D.
J Neuroimmunol. 2011 Dec 15;240-241:52-7. Epub 2011 Oct 26.
More to come: humoral immune responses in MS.
Dobson R, Meier UC, Giovannoni G.
J Neuroimmunol. 2011 Dec 15;240-241:13-21. Epub 2011 Oct 21. Review.
Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
Wang H, Wang K, Zhong X, Dai Y, Wu A, Li Y, Hu X.
J Neuroimmunol. 2012 Feb 29;243(1-2):52-5. Epub 2011 Dec 15.
Neutrophils in multiple sclerosis are characterized by a primed phenotype.
Naegele M, Tillack K, Reinhardt S, Schippling S, Martin R, Sospedra M.
J Neuroimmunol. 2012 Jan 18;242(1-2):60-71. Epub 2011 Dec 9.
The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.
Toepfner N, Cepok S, Grummel V, Hemmer B.
J Neuroimmunol. 2012 Jan 18;242(1-2):47-51. Epub 2011 Dec 1.
Proteomics technologies for biomarker discovery in multiple sclerosis.
Singh V, Hintzen RQ, Luider TM, Stoop MP.
J Neuroimmunol. 2011 Nov 28. [Epub ahead of print]
IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.
Chen M, Chen G, Deng S, Liu X, Hutton GJ, Hong J.
J Neuroimmunol. 2012 Jan 18;242(1-2):39-46. Epub 2011 Nov 21.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on